Alok Ranjan
Postdoctoral fellow at National Institute of Health (NIH)/ National Cancer Institute (NCI), Clinical Center, Bethesda, MD

Dr. Ranjan received his Bachelor?s degree in Pharmaceutical Sciences from India in 2010, where he was ranked #1 for two consecutive years at Bachelor?s level. He started his doctoral research in the Department of Biomedical Sciences at Texas Tech University Health Sciences Center in the fall of 2012. During his graduate study, he served as Chair and Vice-President of American Association of Pharmaceutical Scientists students? chapter of Texas Tech University, Amarillo. Dr. Ranjan?s doctoral research on cancer and metastasis earned him Scholar-In-Training Award at American Association for Cancer Research (AACR) and Graduate Student Research Award in Biotechnology at American Association of Pharmaceutical Scientists (AAPS). He defended his dissertation in December 2016 and was awarded with Outstanding Graduate Student of the Year award. After graduating, Dr. Ranjan joined the Thoracic and Gastrointestinal Oncology Branch at National Cancer Institute (NCI)/National Institute of Health (NIH) as a postdoctoral fellow in the lab of Dr. Hernandez in March 2017.

Hidehiro Hojo
Physician (Hepatobiliary & GI malignancy), Division of Radiation Oncology and Particle Therapy, National Cancer Center Hospital East, Chiba, Japan

Lewiecki EM
New Mexico Clinical Research & Osteoporosis Center, USA

E. Michael Lewiecki, MD, is Clinical Assistant Professor of Medicine at University of New Mexico School of Medicine and Director of New Mexico Clinical Research & Osteoporosis Center. His is a consultant in osteoporosis and metabolic bone disease, supervisor and interpreter of bone density studies at his center, and an educator with a special interest in the management of osteoporosis and metabolic bone disease. He is principal investigator for the center\'s osteoporosis clinical trials and author of many scientific publications on osteoporosis and bone densitometry. Dr. Lewiecki is past-president of the International Society for Clinical Densitometry (ISCD). He is a faculty member for the ISCD educational programs in bone densitometry, vertebral fracture assessment, and management of osteoporosis. Dr. Lewiecki is Senior Editor of Clinical Investigation, Associate Editor of the Journal of Clinical Densitometry, and Editorial Board member of Osteoporosis International and other peer-reviewed journals. He has received national and international awards, including \" Physician of the Year \" by the ISCD in 2002, the ISCD \" Paul D. Miller Service Award \" in 2006, and the \" Laureate Award \" of the New Mexico Chapter of the American College of Physicians in 2006. He is a fellow of the American College of Physicians and the American College of Endocrinology. Dr. Lewiecki is president and founder of the Osteoporosis Foundation of New Mexico and director of its educational activities. He is past-president of the New Mexico Society of Internal Medicine and past-president of New Mexico Medical Group. He established and is program director of the annual Santa Fe Bone Symposium. Dr. Lewiecki, who was raised in the Boston area, is a graduate of Amherst College and Northwestern University Medical School. He completed postgraduate medical training at University of New Mexico Health Sciences Center and now resides in Albuquerque, New Mexico.

Volpe M
University La Sapienza of Rome, Italy

Massimo Volpe is Full Professor of Cardiology and of Internal Medicine and is currently Chairman of Cardiology and of the Specialty School of Cardiology, at the University of Rome ?La Sapienza?. He is Chief of the Cardiology Division and of the Department of Cardiovascular and Thoracic Science and of the Hypertension Unit (recognized as Centre of Excellence) at Sant?Andrea Hospital; Rome, Italy. His main fields of research include neurohormonal control of circulation and cardiovascular structural and functional abnormalities in hypertension and heart failure. Professor Volpe has led many research programs in the field of hypertension pathophysiology and cardiovascular prevention and has participated in several large international clinical trials (ONTARGET, VALIANT, I-PRESERVE, HEAAL, OCTAVE APROS DYADIS, PLATO, TRILOGY, TRACER, ASPIRE ATMOSPHERE), according to GCP guidelines. He has been IN THE Steering Committee of I-SEARCH, I-DEMAND and he is Italian Coordinator of ASTRONAUT. He coordinates multicenter research finalized programs of Italian Ministry of Health and Education and has also received financing from: National Research Council, NATO and, European Union (Network of Excellence of the VI Framework Programme). He has authored more than 500 publications on the most prestigious cardiovascular peer-reviewed national and international journals (including Nature Genetics, Cinical Invest, Circulation, Hypertension, Fed. Proc., JACC, PNAS, J Hypertens, etc.).

Archana Sinha
Ozarks medical Center, West Plains, Missouri, USA

Archana Sinha, MD, FACC finished her medical school from B.J. M.C., Pune, India. She completed Internal Medicine residency from Howard University Hospital, Washington DC and Cardiology fellowship from Saint Luke?s University Hospital, Bethlehem, USA. She is proud recipient of prestigious National Science fellowship award and Alpha Omega Alpha award. She is certified by the American Board of Internal Medicine and is an active member of the American College of Physicians, American College of Cardiology, American Heart Association, Association of Black Cardiologists and Alpha Omega Alpha Honor Medical Society. She is currently working at Ozarks medical Center, West Plains, Missouri, USA. She has a keen interest in research and has published several papers in peer reviewed journals. She has presented her work at National and International Conferences and has served as reviewer for several journals.

Perbinder Grewal
University Hospital Southampton, UK

Perbinder Grewal MBBS, FRCS is a Consultant Surgeon at University Hospital Southampton, UK. His main interests are in General & Vascular Surgery. He is on the editorial board of Medicine Journal and Clinical Investigation Journal. He is a module tutor for the ChM Vascular and ChM General surgery at Edinburgh University. He is ex-lead for e-learning for healthcare at the Royal College of Surgeons England. He has authored a number of papers and supervised Masters students. He completed medical training at Imperial College before moving to Oxford to finish his junior surgical training. His higher surgical training in General and Vascular Surgery was in London with a year spent in Paediatric surgery. He now works and lives on the South Coast of England.

Angiolillo DJ
University of Florida College of Medicine-Jacksonville, USA

Dominick J Angiolillo is Assistant Professor of Medicine and Director of Cardiovascular Research and the Center for Thrombosis Research at the University of Florida College of Medicine in Jacksonville. Dr Angiolillo graduated with full honors from the Catholic University of the Sacred Heart Medical School in Rome, Italy, where he completed training in Medicine and Cardiology. He subsequently pursued training in Interventional Cardiology at the Complutense University of Madrid in Spain. Ultimately, Dr Angiolillo received his PhD in Cellular and Molecular Cardiology. Much of Dr Angiolillo's professional career has been devoted to cardiovascular research in the field of interventional cardiology and acute coronary syndrome. His largest international recognition has been for his pivotal contributions in the field of thrombosis. In particular, Dr Angiolillo has performed seminal studies on platelet function and modulation of antiplatelet drug response, including genetic studies, for which he has received numerous academic recognitions. He has also been a key investigator in the clinical development of numerous novel antithrombotic agents. Dr Angiolillo has made major scientific contributions to many cardiovascular journals as well as textbooks of cardiovascular medicine. He has authored ~ 150 articles in peer-reviewed journals, 300 abstracts presented at national and international meetings, and 15 book chapters, and he is the editor of his own textbook on antithrombotic medicine. Dr Angiolillo is an active member of many cardiovascular societies in the Unites States and Europe. In addition, he is on the editorial board of numerous cardiovascular journals and is a scientific reviewer for many major journals and extramural funding agencies.

Coca A
University of Barcelona, Spain

Antonio Coca is Professor of Internal Medicine, Senior Consultant, Chief of the Hypertension Unit, Director of the Department of Internal Medicine, and Director of the Institute of Medicine and Dermatology, Hospital Clinic, School of Medicine, University of Barcelona, Spain. He obtained his M.D. degree in 1974 from the School of Medicine, University of Barcelona, Spain. In 1983 he obtained a Ph.D. (summa cum laude) from the University of Barcelona. He served as an Associate Professor at the University of Barcelona from 1975 to 1986, as a Research Associate Professor at the Laboratory of Cardiovascular Physiology and Pharmacology (INSERM, CNRS, Hospital Necker, Paris, France) in 1986, and as a Professor of Medicine at the School of Medicine, University of Barcelona from 1986. In 1992, he assumed the position of Chief of the Hypertension Unit at the Hospital Clinic. Since 1999 he has been Director of the Institute of Internal Medicine and Dermatology, Hospital Clinic, University of Barcelona. Dr Coca is a past President of the Spanish Society of Hypertension, and in 2007 was elected as a member of the Scientific Council of the European Society of Hypertension. He has served as President of the Hypertension Research Foundation of the Catalan Community Hospitals since 1992. Dr. Coca is Fellow of the Royal College of Physicians of London. He has received research grants from Spanish and European Research Institutes (European Union, Fondo de Investigación Sanitaria, Comisión Asesora de Investigación Científica y Técnica) and the pharmaceutical industry from 1982 to the present. He is Editor or co-Editor of forty-five books on different subjects connected with hypertension. He has published more than 250 papers and has presented more than 300 invited lectures at international and national meetings.

Krum H
Monash University, Australia

Weitz J
Hamilton General Hospital, Canada

Valgimigli M
University of Ferrara, Italy

Marco Valgimigli was born on 6th March 1972 in Forlì, Italy. He obtained his medical degree in 1997 with Summa cum Laude at the University of Bologna, Italy. He performed his training in internal medicine at the University of Bologna in 1997-1999 and completed the training in cardiology at the University of Ferrara in 2003. In January 2004, he started a clinical and research fellowship in the catheterisation laboratory of the Thoraxcenter, Erasmus Medical Centre in Rotterdam, under the supervision of Prof Patrick Serruys. In November 2005, he moved to Caen, Normandy, France to be trained in transradial approach under the supervision of Prof Martial Hamon. In June 2006 Marco Valgimigli took up the position of Senior Cardiologist at the S. Anna Hospital of Ferrara which then led to the position of Director of the Catheterisation Laboratory in December 2009.

Menter A
Baylor Research Institute, USA

Alan Menter, born in England, is a graduate of the Medical School of the University of Witwatersrand, South Africa. He completed his dermatology residency at Pretoria General Hospital at the University of Pretoria, also in South Africa, and fellowships at Guys Hospital and St John?s Hospital for diseases of the skin, both in London, UK, plus the University of Texas Southwestern Medical Centre at Dallas. Dr Menter joined Baylor University Medical Centre at Dallas in 1975 and received his American Academy of Dermatology board certification in 1977. Currently he serves as Medical Director of the Baylor Psoriasis Center, Chair of Research for Dermatology at Baylor Research Institute, and Program Director, Dermatology Residency Program, Baylor University Medical Center. Dr Menter held the position of Clinical Director of the National Psoriasis Foundation Tissue Bank from 1996 to 2002. Dr Menter is also Clinical Professor of Dermatology at UT Southwestern Medical School in Dallas and currently President of the International Psoriasis Council. Dr Menter?s resume lists some 245 articles, 3 books, and several book chapters. He was co-author of the first gene discovery for psoriasis, published in Science in 1994. His extensive research on psoriasis runs the gamut from topical and phototherapy, to systemic and biologic therapy, to mapping of genetic patterns of psoriasis susceptibility. His clinical practice includes over 1,100 patients on systemic oral and biologic therapy.

Eichenfield LF
University of California at San Diego, USA

Lawrence F. Eichenfield is Chief of Pediatric and Adolescent Dermatology at Rady Children's Hospital-San Diego, and Professor of Pediatrics and Medicine (Dermatology), at the University of California, San Diego (UCSD) School of Medicine. He earned his medical degree from Mount Sinai School of Medicine in New York, was a pediatric resident and chief resident at Children's Hospital of Philadelphia, and completed dermatology training at the Hospital of the University of Pennsylvania. He has been board certified in pediatrics, dermatology and pediatric dermatology. Dr. Eichenfield's clinical interests include atopic dermatitis, acne, vascular lesions (port wine stains, hemangiomas), neonatal dermatology, laser surgery, procedural pain control, nevi (moles), and skin signs of systemic disease. He is Editor-in-Chief of Pediatric Dermatology and serves on the editorial boards of several journals and periodicals. Dr. Eichenfield has published more than 200 journal articles, chapters and abstracts, and books including serving as editor of Neonatal Dermatology, 2nd Edition, published by W.B. Saunders, and The Eczemas published by Summit Communications. Dr. Eichenfield was honored as a member of the Alpha Omega Alpha Medical Honor Society during medical school, as a recipient of the Benjamin Ritter Award at Children's Hospital of Philadelphia, and has received excellence in teaching awards from UCSD Pediatrics, UCSD Dermatology, and Children's Hospital, San Diego. He has been named one of the "Best Doctors in America" since 1994. Dr. Eichenfield is past president of the Society for Pediatric Dermatology, has served on the Board of the American Academy of Dermatology, and is a founding board member of the American Acne & Rosacea Society.

Weinberg JM
Columbia University College of Physicians and Surgeons, USA

Jeffrey M. Weinberg is an assistant clinical professor of dermatology at Columbia University College of Physicians and Surgeons in New York City. In addition, he is director of the Clinical Research Center/Dermatopharmacology at St. Luke?s-Roosevelt Hospital Center and acting director of the Division of Dermatology at Jamaica Hospital Medical Center, both in New York City. Dr. Weinberg graduated from the University of Pennsylvania School of Medicine in Philadelphia and completed an internship in medicine at Columbia-Presbyterian Medical Center in New York City. He then completed a residency in dermatology at the University of Pennsylvania School of Medicine. Dr. Weinberg is a Fellow of the American Academy of Dermatology, where he has served on several committees, and a member of the Dermatology Foundation. He is a diplomat of the American Board of Dermatology. Dr. Weinberg is on the editorial board and is a senior editor of Cutis. He is on the international editorial board of the American Journal of Clinical Dermatology and the manuscript review board of Hospital Physician, and is a reviewer of Archives of Dermatology, Pediatric Dermatology and the American Journal of Clinical Dermatology. His clinical research encompasses a variety of dermatology-related topics, including studies of diagnostic methods in the evaluation of onychomycosis. He has been principal or co-investigator for several clinical trials. In addition, he has written or co-authored numerous articles for professional journals such as Cutis, the Journal of the American Academy of Dermatology, and Blood, as well as reviews, book chapters and abstracts.

Feng Wang
Computational Scientist, MD Anderson Cancer Center, Houston, Texas

Buynak R
Northwest Indiana Center for Clinical Research, USA

Robert Buynak is a graduate of Harvard Medical School, a general practitioner, and a clinical instructor at Indiana University School of Medicine. He has served as a principle investigator on over 50 clinical trials and has served as co-author of multiple scientific manuscripts. His book Dr. Buynak's 1-2-3 Diabetes Diet was published by the American Diabetes Association in 2007.

Del Prato S
University of Pisa, Italy

Gerich JE
University of Rochester, USA

John E. Gerich is Professor of Medicine at the University of Rochester School of Medicine, Program Director of the Institution?s Clinical Research Center and Head of its Diabetes Research Laboratory. Dr. Gerich graduated Cornell University magna cum laude with honors in Classics, received his MD and Residency training in Internal Medicine at Georgetown University and trained in Endocrinology at the University of California in San Francisco under Dr. Peter Forsham. Before coming to the University of Rochester, Dr. Gerich served on the faculty of the University of California (San Francisco), Mayo Clinic, University of Pittsburgh, and the University of California (San Diego). Dr. Gerich has over 500 publications in the fields of Diabetes, Endocrinology and Metabolism. Over the past 30 years, he has trained more than 40 research fellows and serves on the editorial boards of several journals. He is the Regional Editor of Diabetes Research and Clinical Practice for North, South, and Central America. Dr. Gerich is internationally renowned as a diabetes investigator and in recognition of his achievements, Dr. Gerich has received numerous awards and lectureships including: 1975 Rumbrough Research Award from the Juvenile Diabetes Association; the 1975 J. D. Lane Award for Scientific Research from the United States Public Health Service Professional Association; the 1985 Connaught Lectureship from the Annual Meeting of the Canadian Diabetes Association; the 1988 Lilly Award from the American Diabetes Association; the 1990 Rolf Luft Award from the Karolinska Institute; the 1991 Stadie Award from the American Diabetes Association, Pennsylvania; the 1992 Charles H. Best Lecture from the Toronto Diabetes Association; the 2001 Ricardo E. Fernando Medal from the Philippine Society of Diabetologists; and the 2007 Novartis Prize in Diabetes for Long-Standing Achievement.

Lichtenstein GR
University of Pennsylvania, USA

Kuipers EJ
Erasmus Medical University Center, The Netherlands

Ernst Kuipers is Professor of Medicine and chair of the Departments of Gastroenterology and Hepatology, and Internal Medicine of the Erasmus MC University Medical Center, Rotterdam, the Netherlands. He is/has been a member of the editorial boards of various international journals in the field of Gastroenterology. His research interests include peptic ulcer bleeding, H. pylori, and early neoplastic conditions of the gastrointestinal tract. Ernst Kuipers is a member of the Dutch National Health Council, President of the Dutch Society of Gastroenterologists, and fellow of the American Gastroenterology Association.

Cornely O
University Clinic of Cologne, Germany

Oliver Cornely is Professor of Internal Medicine, Attending Physician and Head of the Clinical Trials Unit of Infectious Diseases at the Klinik I für Innere Medizin, and Director of the Center of Clinical Trials (ZKS Köln), Director of the Translational Platform of the Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD), all located at the University Hospital of Cologne, Germany. Dr Cornely received his medical degree from the University Hospital at Albertus Magnus University, Cologne, in 1994, where he also completed his residency. He is board certified in internal medicine, haematology, oncology, infectious diseases, and emergency medicine. He is the president of the European Confederation of Medical Mycology, past-President of the German-speaking Mycological Society, and co-founder of the Infectious Diseases Study Group of the German Society of Hematology/Oncology (DGHO). He serves as clinical trial advisor to the German Society of Infectious Diseases, on the ICAAC program committee of the American Society for Microbiology, and is a fellow of the Infectious Diseases Society of America. Dr Cornely?s research interests include the diagnosis and treatment of infections in immunocompromised hosts and the principles of translational and clinical research across various disciplines.

Shwetank Fnu
Prof. Aron Lukacher\'s Lab, Dept of Microbiology and Immunology, Penn State College of Medicine, Hershey, PA

I got my PhD from Dept. Of Biochemistry, Indian Institute of Science (IISc) in cellular immune response to flaviviruses. Currently pursuing my Postdoctoral research at Penn State College of Medicine, PA, USA in the field of Innate and adaptive immune response to polyomavirus. I am Editorial Board member for Journal of Autoimmunity and Cell Responses and Immunotherapy (open access Journal). In past, I have reviewed research articles for Journal of Immunological Techniques in Infectious Diseases, Journal of Clinical & Cellular Immunology, Immunome Research, Rheumatology, Clinical Microbiology, PLoS Pathogen and Virus Research. I myself have book chapter, research articles in Journal of Immunology, Journal of Autoimmunity, PLoS One and Immunology letters. I am also India coordinator, Project Brahma (http://www.biodiversityofindia.org). Responsibilities: Public relations and communications head and Content editor. My area of expertise are anti-viral immunity, NK cells immunology, T cell activation and memory differentiation, Flaviviruses, Polyomaviruses, Immunology of Brain and Autoimmunity.

Barreiro P
Hospital Carlos III, Spain

Pablo Barreiro was born in Madrid, March 10th 1969. He received his PhD in Internal Medicine from the Universidad Complutense de Madrid. He is currently at the Department of Infectious Diseases, Hospital Carlos III where he is responsible for the HIV/AIDS Cohort and Phase I Studies Unit. Dr Barreiro is also a WHO Technical Consultant on HIV and Hepatitis co-infection and NIH Grant Reviewer (WIHS IV, Limited Competition U01, [RFA-AI-07-004] and U.S.-India bilateral collaborative research partnerships on the prevention of HIV/AIDS [R21]). His research interests include resistance, pharmacokinetics and pharmacogenetics of antiretrovirals; therapy for HIV, HBV and HCV infection; the study of liver fibrosis and reproductive advice. Dr Barreiro has co-authored over 130 articles in peer-reviewed PubMed indexed journals.

Cahn P
Fundacion Huesped, Argentina

Crandon J
Hartford Hospital, USA

Kuti JL
Hartford Hospital, USA

Joseph Kuti is Associate Director of Clinical and Economic Studies at the Center for Anti-Infective Research and Development at Hartford Hospital in Hartford, Connecticut. He received his Bachelor of Science and Doctor of Pharmacy degrees from Rutgers University, College of Pharmacy in Piscataway, New Jersey. While completing his doctorate, he served as a clinical pharmacist for the medical and surgical intensive care units at Robert Wood Johnson University Hospital in New Brunswick, New Jersey. He then completed a post-doctorate fellowship in Antibiotic Management and Pharmacoeconomics at Hartford Hospital. Dr Kuti also holds an Adjunct Assistant Professor appointment at the University of Connecticut School of Pharmacy in Storrs, Connecticut. He is a member of the American Society for Microbiology, the American College of Clinical Pharmacy, and the Society of Infectious Diseases Pharmacists. Dr Kuti?s primary area of research includes the pharmacokinetics, -dynamics, -economics, and outcomes of antimicrobial therapy in severe infections. His research has been published in many original research articles, book chapters, and reviews; furthermore, it has led to implementation of numerous clinical programs designed to optimize antibiotic care of hospitalized patients.

Ostrosky-Zeichner L
University of Texas Medical School at Houston, USA

Luis Ostrosky-Zeichner obtained his medical degree from Universidad Nacional Autonoma de Mexico. He completed his internal medicine residency at Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, and his infectious diseases fellowship at the University of Texas Medical School at Houston and MD Anderson Cancer Center combined fellowship program. He has advanced training and experience in medical mycology and hospital epidemiology.He is currently an associate professor of medicine and epidemiology, and the director of the Laboratory of Mycology Research, at the Division of Infectious Diseases of the University of Texas Medical School at Houston. He also serves as the associate fellowship program director and medical director for epidemiology for Memorial Hermann Texas Medical Center. He is a fellow of the American College of Physicians and the Infectious Diseases Society of America. He is an editorial board member of prestigious scientific journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine, and Journal of Clinical Microbiology. Dr. Ostrosky-Zeichner actively pursues translational and clinical research in medical mycology and hospital epidemiology, having over 100 publications in both fields. His areas of expertise include: antifungal susceptibility testing, fungal serologies, PK/PD of antifungals, in vivo models of human mycoses, immunology, and clinical trials in prophylaxis and treatment of fungal infections, as well as hospital epidemiology and infection control.

Sinerik Ayrapetyan
Life Sciences International Postgraduate Educational Center, UNESCO Chair, Yerevan Armenia, 0040, Avan, Acharian 31

Prof. Sinerik Ayrapetyan has received his PhD in Cell Biophysics in the Institute of Physiology of Ukraine Academy of Sciences, Kiev during the period of 1966-1970. Currently, he is the coordinator of UNESCO Chair at Life Sciences International Postgraduate Educational Center, Yerevan, Armenia. His research has included the study of metabolic regulation of cell function in norm and pathology. He is serving as a Chief Editor for the Journal of ?Bioequivalence and Bioavailability?, and an editorial member of several reputed journals like ?Electromagnetic Biology and Medicine?, ?ISRN Biophysics?, ?European Journal of Biophysics?, ?Advances in Life Sciences\", ?Applied Pharmacy?, ?BBA General Subjects?, ?International Dental and Medical Research\", ?International Journal of Basic and Applied Sciences?, ?Insights of Medical Sciences?, ?Chronicles of Pharmaceutical Science Journal?, ?Clinical Investigations? etc. Prof. Sinerik Ayrapetyan is a member of a number of international societies, such as International Society of Invertebrate Neurobiology (ISIN) European Society for Neurochemistry (ESN), International Brain Research Organization (IBRO), International Union of Pure and Applied Biophysics (IUPAB) Bioelectromagnetics Society (BEMS), WHO International Advisory Committee on Electromagnetobiology and the president of ?All Armenian Research Council?. He has authored 7 international books and 115 research articles.

Comi G
IRCCS Fondazione Centro San Raffaele del Monte Tabor, Italy

Freedman MS
University of Ottawa, Canada

Korczyn AD
Tel Aviv University, Israel

Perucca E
University of Pavia, Italy

Sreejata Chatterjee
University Manor East, Hershey, PA, USA

Sreejata did her PhD in Neurophysiology from the Indian Institute of Science, Bangalore, India. Her PhD thesis looked into the dose dependent effect of stress hormones on neuron astrocyte interactions using Patch clamp technology and live cell Calcium Imaging. Currently she is a Postdoctoral research fellow at the Penn State College of Medicine at Hershey, PA. Her research involves understanding the pathomechanisms of carcinogenesis by human tumor viruses. Her interests include pathway and network analysis of the cancer genomes. She has published several manuscripts in prestigious journals like GLIA, Journal of neurochemistry, PLoS Genetics, ACS Chemical Neuroscience and Pigment Cell Research. She has also been very active in peer reviewing manuscripts for several reputed journals. Her areas of expertise are neuroscience, virology and cancer.

Zielinski C
Medical University Vienna, Austria

Cervantes A
University of Valencia, Spain

Ciardiello F
Seconda Universita di Napoli in Naples, Italy

Demetri GD
Dana-Farber Cancer Institute, USA

Giles FJ
Northwestern Medicine Developmental Therapeutics Institute, USA

Gridelli C
S.G. Moscati, Hospital of Avellino, Italy

Markman M
University of Texas M. D. Anderson Cancer Center, USA

Mok T
University of Hong Kong, Hong Kong, China

Tony Mok studied medicine at the University of Alberta in Canada and, following his residency there and fellowship training at Princess Margaret Hospital in Toronto, spent a further 7 years practicing in the fields of oncology and internal medicine. In 1996, Prof Mok moved to Hong Kong after gaining a position as Assistant Professor in the Department of Clinical Oncology at the Chinese University of Hong Kong in Prince of Wales Hospital. In 2007, he was made full Professor within the department and also attained an honorary professorship at the Guangdong Provincial People's Hospital in Guangdong, China and guest professorship at Peking University School of Oncology. Widely published in the field of oncology, Prof Mok is also heavily involved in several professional societies and committees, including the Board of Director of IASLC, chair of the International Affair Committee of ASCO, vice secretary of the Chinese Society of Clinical Oncology and chairmen of Hong Kong Cancer Therapy Society. In addition, he is the Associate Editor of the Journal of Thoracic Oncology, Clinical Lung Cancer and Asia Pacific Journal of Clinical Oncology and is on Editorial Board of Journal of Clinical Oncology and several other major oncology journals. He has presented extensively at various international congresses and is particularly interested in the application of novel therapeutic approaches in the treatment of lung and liver cancer.

Pfisterer J
Gynecologic Oncology Center, Germany

Posner MR
Mount Sinai School of Medicine, USA

Marshall Posner is an associate professor of medicine at Harvard Medical School, Medical Director of the Head and Neck Oncology Program at the Dana-Farber Cancer Institute and Director of the Human Monoclonal Antibody Laboratory of Beth Israel Deaconess Medical Center in Boston, Massachusetts. He also serves on the active staff of the Division of Adult Oncology at the Brigham and Women?s Hospital, in Boston, and in the Department of Adult Oncology at the Dana-Farber Cancer Institute. Dr. Posner received his MD from Tufts University School of Medicine, and completed his internship and residency in internal medicine at Boston City Hospital and a fellowship in medical oncology at the Dana-Farber Cancer Institute. He is a current or past member of the editorial boards of several journals, including the Journal of Clinical Oncology, American Journal of Clinical Oncology, Oral Oncology, The Oncologist, and Head and Neck, and he serves as an ad hoc reviewer for, among others, The New England Journal of Medicine, Cancer, Journal of Immunology, Clinical Cancer Research, Cancer Research, British Journal of Cancer, and Oncology. Dr. Posner has been a member of the National Institutes of Health Review Committees for the NIH Inter-Institute Program and the Specialized Programs of Research Excellence in Human Cancer, Head & Neck Cancer, and of the National Cancer Institute?s Special Emphasis Panel for phase II Contracts. He has published over 180 peer-reviewed basic laboratory and clinical studies, as well as multiple reviews and abstracts. He holds patents for Human Monoclonal Antibodies to viral and bacterial antigens. Dr. Posner has been the principal investigator on numerous clinical and translational research trials as well as multiple phase 1 and 2 trials. He has been the Principal Investigator on International Phase III trials in head and neck cancer and has reported on antibody based immunotherapy in pemphigus and HIV and adoptive immunotherapy in nasopharynx cancer.

Reck M
Krankenhaus Großhansdorf, Germany

Robak T
Medical University of Lodz, Poland

Tadeusz Robak is Professor of Hematology at the Medical University of Lodz and since 1997 has been Head of the Department of Hematology at the Medical University and Copernicus Memorial Hospital in Lodz. Professor Robak studied medicine at the Medical University of Lodz and was approved as haematologist in 1985 and as clinical pharmacologist in 1987. He undertook further postgraduate training in 1983?1984 at Hammersmith Hospital and the Royal Postgraduate Medical School, London, UK. In 1996 Professor Robak became county consultant haematologist for the Lodz region, and in 1996?2002 he was vice-rector and rector of the Medical University of Lodz. Professor Robak is Chair of the chronic lymphocytic leukaemia (CLL) subgroup of the Polish Adult Leukemia Study Group and a member of the American Society of Hematology (ASH), European Hematology Association (EHA), European Society of Medical Oncology (ESMO), and Polish Society of Hematology. He has written more than 500 journal articles, most published in well-regarded peer-reviewed journals, and numerous abstracts and books or book chapters. His special interests are in chronic and acute leukaemias and lymphoma, with particular emphasis on the use of purine analogues and monoclonal antibodies in the treatment of leukaemia and lymphoma. Professor Robak was principal investigator of the Polish multi-centre phase 3 trials of cladribine in CLL and hairy cell leukaemia and, recently, of the large international REACH trial in relapsed/refractory CLL. He is editor-in-chief of Acta Haematologica Polonica and reviewer for numerous journals, including Blood, Leukemia, Leukaemia and Lymphoma, the Lancet, and others; he also serves on 10 international journal editorial boards. Professor Robak has been selected by the World Scientists Forum of the International Research Promotion Council (IRPC) for the ?Eminent Scientist of the Year 2010? award in haematology-oncology.

Sternberg CN
San Camillo Forlanini Hospital, Italy

Cora N. Sternberg is Chief of the Department of Medical Oncology at the San Camillo and Forlanini Hospitals in Rome. Her particular interests are genitourinary cancers, and the use of molecular-targeted agents for the treatment of renal cell carcinoma and prostate cancer. Professor Sternberg trained at the University of Pennsylvania, USA, and later completed her fellowship in Medical Oncology and was on staff at the Memorial Sloan-Kettering Cancer Center in New York. After moving to Italy, she held the positions of Consultant Physician at the Regina Elena Cancer Institute for Cancer Research in Rome and was Chief of the Department of Medical Oncology at the San Raffaele Scientific Institute in Rome. Since 2002, Professor Sternberg has been the Chairman of the Department of Medical Oncology at the San Camillo and Forlanini Hospitals, as well as Professor at La Sapienza University in the First and Second Faculties of Medicine in the School of Medical Oncology Specialization. Prof. Sternberg is also Adjunct Professor of Urology and Urologic Oncology at Tuft?s University School of Medicine and the Lahey Clinic in Boston, and Adjunct Professor in Temple University?s College of Science and Technology in Philadelphia. Professor Sternberg is a member of numerous scientific and medical societies, is an elected Board Member of the EORTC and is Coordinator of Genitourinary Oncology Education for the European Society for Medical Oncology. She has published more than 200 peer-reviewed articles, lectured internationally and is the editor of four recent medical oncology textbooks.

Zwierzina H
Innsbruck Medical University, Austria

Schmidt-Erfurth U
Medical University of Vienna, Austria

Meltzer H
Northwestern University, USA

Pae C-U
The Catholic University of Korea College of Medicine, Seoul, South Korea

Chi-Un Pae is working as an Associate professor at the Department of Psychiatry, Bucheon St. Mary's Hospital, The Catholic University of Korea College of Medicine. Dr. Pae has been teaching, leading research and taking care of patients in clinical and research setting since 2000 after acquisition of national board certificates of psychiatry in South Korea. Dr. Pae has been doing research activities focusing on psychiatric genetics and clinical psychopharmacology. Dr. Pae has proposed and successfully completed international collaboration studies. In addition, Dr. Pae has accomplished a number of academic achievment in particular, for psychiatric genetics and clinical psychopharmacology. Dr. Pae has been actively involving in SCI peer-review journals and national peer-review journals. Dr. Pae has received many awards from national and international research societies. Dr. Pae has published more than 200 articles including original, review, case report and editorials at SCI peer-review journals as the first or corresponding author indicating his superb productivity at academic field. Dr. Pae has also finished his Clinical Psychopharmacolgy Fellow Course at Clinical Trials Program at Duke Psychiatry under supervision of Drs. Patkar, Masand and Steffens with an excellence from 2005-2008. Dr. Pae has clinical expertise in the treatment of wide variety of major psychosis and mood disorders such as schizophrenia and bipolar disorders. Dr. Pae's future research project will be focusing on the Imaging-pharmacogenomics for schizophrenia and mood disorder, so that he will continue to contribute to the research field for the study of up-to-date pathogenesis and treatment for major psychiatric disorders. Dr. Pae has been also working as an Adjunct Associate Professor of Department of Psychiatry and Behavioral Sciences at Duke University from 2008.

Pollack MH
Massachusetts General Hospital, USA

Roth T
Henry Ford Hospital, USA

Thase ME
University of Pennsylvania, USA

Trivedi MH
University of Texas Southwestern Medical Center, USA

Madhukar H. Trivedi, M.D. is currently a Professor and Chief of the Division of Mood Disorders in the Department of Psychiatry at the University of Texas Southwestern Medical Center at Dallas. He holds the Betty Jo Hay Distinguished Chair in Mental Health. Dr. Trivedi is an established efficacy and effectiveness researcher in the treatment of depression. He has focused his research on pharmacological, psychosocial, and other non-pharmacological treatments for depression. Dr. Trivedi has published over 310 articles and chapters related to the Diagnosis and Treatment of Mood Disorders.

Cazzola M
Universita di Roma "Tor Vergata", Italy

Mario Cazzola is Associate Professor of Respiratory Medicine and Coordinator of the Postgraduate School of Respiratory Medicine at the University of Rome "Tor Vergata" Rome, Italy and Visiting Senior Lecturer at the Sackler Institute of Pulmonary Pharmacology, GKT School of Biomedical Sciences, London, UK. Prof. Cazzola has devoted his research to pharmacology of airway diseases, particularly use of bronchodilators in chronic obstructive pulmonary disease, and respiratory infections, particularly use of antimicrobial drugs. He is the author or co-author of 442 scientific papers and book chapters, editor and author of 10 monographs or books and 245 abstracts. He serves as the Editor-in-Chief for Therapeutic Advances in Respiratory Disease, the Executive Editor for Pulmonary Pharmacology & Therapeutics, an Associate Editor for Respiratory Medicine, for Respiratory Research, and for Breathe, as Co-Editor-in-Chief of Aria, Ambiente e Salute, and is an Editorial Board Member for Respiration, International Journal of Chronic Obstructive Pulmonary Disease, Monaldi Archives for Chest Diseases, International Journal of Respiratory Care, Current Pulmonary Medicine Reviews, Current Drug Therapy, Current Patents on Anti-Infective Drug Discovery, Expert Review of Respiratory Medicine, Journal of Pharmacogenomics & Pharmacoproteomics, Giornale Italiano di Medicina Toracica, Rassegna di Patologia Respiratoria e Quaderni di Medicina e Chirurgia. He was the Chairman of the Airway Pharmacology and Treatment Group and the Secretary of the Inflammatory Airway Diseases and Clinical Allergy Assembly and is the Postgraduate Courses Director at the European Respiratory Society. He was the Co-chairman of the European Respiratory Society/American Thoracic Society Task Force "Outcomes for COPD pharmacological trials: from lung function to biomarkers". He is a member of the steering committee of the Airway Disorders Network at the American College of Chest Physicians, and the Chairman of the Southern Europe Chapter at Interasma.

Adcock IM
Imperial College London, UK

Mullol J
Hospital Clínic, Spain

Joaquim Mullol, MD and PhD, earned his medical degree (1982) and PhD (1991) at the University of Barcelona, completed a residency in Otorhinolaryngology (1984-88) in Barcelona and a research fellowship in the Allergic Disease Section and Asthma Center (1989-91), Laboratory of Clinical Investigation, National Institutes of Health, in Bethesda Maryland, USA. Dr Mullol is the director of the Rhinology Unit & Smell Clinic at the ENT Department of the Hospital Clínic i Universitari and Senior Investigator at the Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) in Barcelona, Catalonia, Spain. He has served as Secretary and Chairman of the ENT Section and member of the Executive Committee at the EAACI. Currently, he is member of the ARIA, ARIAenespañol, and GA2LEN Executive Committees, co-chair of EP3OS, and belongs to several international advisory and editorial boards. Dr Mullol's research interests include the mechanism of action of upper airway inflammation with a focus on neurogenic inflammation, the regulation of grandular secretion and mucin production, glucocorticoid resistance, aspirin-induced rhinosinusitis, and the pathophysiology of the sense of smell. He has authored or co-authored over 300 communications in scientific congresses and meetings and over 100 peer-reviewed original articles appearing in international scientific journals.

Niederman MS
Winthrop University Hospital, USA

Michael Niederman is Professor and Vice-Chairman of the Department of Medicine at the State University of New York at Stony Brook, and Chairman of the Department of Medicine at Winthrop-University Hospital in Mineola, New York. He obtained his medical degree from Boston University School of Medicine, and then completed his training in internal medicine at Northwestern University School of Medicine, before undertaking a pulmonary and critical care fellowship at Yale University School of Medicine. His interests lie in respiratory tract infections, and include mechanisms of airway colonization, the management of community- and hospital-acquired pneumonia, the role of guidelines for pneumonia, and the impact of antibiotic resistance on the management and outcomes of respiratory tract infections. He has published over 350 peer reviewed or review articles, and has lectured widely, both nationally and internationally. Dr Niederman served as co-chairman of the committees that created the American Thoracic Society 1993 and 2001 guidelines for the treatment of community-acquired pneumonia and the 1996 and 2005 committees that wrote guidelines for the treatment of nosocomial pneumonia. He was a member of the ATS/IDSA committee that published guidelines for community-acquried pneumonia in 2007. He is also Editor-in-Chief of Clinical Pulmonary Medicine, and has served on the editorial boards of The American Journal of Respiratory and Critical Care Medicine, Critical Care Medicine, and Chest.

Sethi S
University at Buffalo, State University of New York, USA

Sanjay Sethi, MD, is a Professor in the Department of Medicine at the University of Buffalo at the State University of New York (SUNY) where he also completed a fellowship in pulmonary and critical care medicine. He is the Chief of the Division of Pulmonary/Critical Care/Sleep Medicine at the University at Buffalo and the Section Chief for Pulmonary/Critical Care/Sleep Medicine at the Western New York Veterans Administration HealthCare System in Buffalo. Dr Sethi completed his internship and residency in internal medicine at Cook County Hospital in Chicago, Illinois and is board certified in internal medicine, pulmonary disease, and critical care medicine. Dr Sethi's main research interests include respiratory infections and chronic obstructive pulmonary disease, focused on the specific areas of bacterial infection in COPD, epidemiology and clinical implications of antimicrobial resistance and innate lung defense in COPD. Dr Sethi's research has been extensively published in many peer-reviewed medical journals. He is a member of the editorial board for the publications Respiratory Research and Current Respiratory Medicine Reviews and has served as a reviewer for several medical journals. Dr. Sethi is currently active in several professional organizations including the American Thoracic Society. He has served as a consultant on the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines for COPD, and as a member of the Department of Veterans Affairs and Department of Defense COPD Guideline Development Committee. Additionally, he is a distinguished speaker presenting papers both nationally and internationally, many with COPD as the primary focus.

Bruyere O
University of Liege, Belgium

Olivier Bruyère, Ph.D., is currently Adjunct Professor at the Department of Public Health, Epidemiology and Health Economics of the University of Liège. He also works at the Bone and Cartilage Metabolism Unit of the University of Liège. Professor Bruyère is member of the ?Scientific Advisory Board? of the ?European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)? and of the ?International Osteoporosis Foundation (IOF)? as well as member of the ?Osteoarthritis? section and the ?Ethics? section of the ?Group for the Respect of Ethics and Excellence in Sciences (GREES)?. His main field of interest is pharmaco-epidemiology related to rheumatic conditions. Professor Bruyère is on the editorial board of various journals and is the authors of more than 80 international scientific publications and book chapters.

Miyasaka N
Tokyo Medical & Dental University, Japan

Dmochowski R
Vanderbilt University, USA

Roger R. Dmochowski is Professor at the Department of Urology at Vanderbilt University in Nashville, Tennessee. He is also Clinical Assistant Professor in Surgery at the Uniformed Services University of the Health Sciences in Bethesda, Maryland. Dr. Dmochowski received his medical degree from the University of Texas Medical Branch at Galveston. He completed an internship and residency in surgery and urology at the University of Texas Medical School at Houston and at the M.D. Anderson Hospital and Tumor Institute in Texas. In addition, Dr. Dmochowski is subspecialty fellowship trained in female urology, neurourology, urodynamics and reconstructive urology. He is board certified in Urology. Dr. Dmochowski has published over 200 articles and book chapters, 250 abstracts and over 425 visiting professorships, invited lectures and presentations at various national and international meetings. Dr. Dmochowski is on the editorial board for the World Journal of Urology, Neurourology and Urodynamics, International Journal of Urogynecology, European Journal of Urology, Journal of Pelvic Medicine and the AUA Office Education CD-ROM Series. He is a reviewer for the Journal of Urology, Urology, British Medical Journal, International Journal of Urogynecology and British Journal of Urology International. He is a Fellow of the American College of Surgeons, a member of the American Urological Association, International Continence Society and President of the Society of Urodynamics and Female Urology, 2006-2008. Dr. Dmochowski has been granted the Zimskind Award from the Urodynamics Society for his accomplishment in clinical treatment for incontinence. His current research interest are outcomes of incontinence therapies with emphasis on quality of life issues. He is also active in bio materials evaluation.

Penson D
Vanderbilt University, USA

Chapple C
Royal Hallamshire Hospital, UK

Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals and visiting professor at Sheffield Hallam University. He has a particular interest in Functional Reconstruction of the Lower Urinary Tract and the underlying Pharmacological Control Mechanisms. He is Past Director of the European School of Urology and an Adjunct Secretary General to the European Association of Urology. Christopher Chapple trained at the Middlesex Hospital where he subsequently completed his doctorate thesis on Pharmacological Control Mechanisms in the Lower Urinary Tract. His sub-specialist training was at the Middlesex Hospital and Institute of Urology in London and he provides a tertiary service in lower urinary tract reconstructive surgery. He is an active member of many international urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Royal Society of Medicine, The British Medical Association and the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He is editor of the journal Neurourology and Urodynamics. He also serves on the editorial board of several journals such as the British Journal of Urology, European Urology, Surgery and Current Opinion in Urology. Professor Chapple has co-authored over 300 articles in peer-reviewed Journals and has written several books and a number of book chapters.